CVX Vs XOM Stock, Which Energy Play Is Best?
Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…
Buy
53
GPCR Quote, Financials, Valuation and Earnings
Last price:
$26.60
Seasonality move
:
21.87%
Day range:
$25.26 - $27.78
52-week range:
$13.22 - $62.74
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.68x
Volume:
1.1M
Avg. volume:
1.2M
1-year change:
-36.26%
Market cap:
$1.5B
Revenue:
--
EPS (TTM):
-$2.35
Earnings Data
Next earnings date for GPCR
May 09
2025
Most recent earnings per share
-$0.64
Missed by $0.47
(Feb 27/2025)
Consensus Estimate
-$0.17
(Feb 27/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GPCR Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | -- | -- | -- | -$0.24 | -- |
| 05/09/2025 | Q1 | -- | -- | -- | -$0.23 | -- |
| 02/27/2025 | Q4 | -- | -- | -$0.64 | -$0.17 | -$0.47 |
| 11/13/2024 | Q3 | -- | -- | -$0.60 | -$0.19 | -$0.41 |
| 08/08/2024 | Q2 | -- | -- | -$0.54 | -$0.23 | -$0.32 |
| 05/09/2024 | Q1 | -- | -- | -$0.57 | -$0.22 | -$0.35 |
| 03/08/2024 | Q4 | -- | -- | -$0.48 | -$0.21 | -$0.27 |
| 11/17/2023 | Q3 | -- | -- | -$0.63 | -$0.22 | -$0.41 |
| 08/10/2023 | Q2 | -- | -- | -$0.60 | -$0.27 | -$0.33 |
| 05/11/2023 | Q1 | -- | -- | -$0.75 | -$0.37 | -$0.38 |
| 12/31/2022 | Q4 | -- | -- | -$0.31 | -$0.54 | $0.23 |
| 09/30/2022 | Q3 | -- | -- | -$0.49 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.61 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.51 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.61 | -- | -- |
Structure Therapeutics Earnings Questions
-
How Much did Structure Therapeutics Generate in Revenue Last Quarter?
Structure Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Structure Therapeutics Beat Earnings Last Quarter?
Structure Therapeutics announced earnings per share of -$0.64 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Structure Therapeutics Profitable?
Structure Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Structure Therapeutics EPS Next Year?
Structure Therapeutics's earnings are forecast to decrease from -$2.34 per share to -$0.76 per share next year representing a decrease of -70.86%.
-
When is Structure Therapeutics's Earnings Date?
Structure Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is it Safe to Invest in Google With OpenAI Threats?
For the last 20 years, Google parent company Alphabet (NASDAQ:GOOG,…
Is Broadcom Stock a Millionaire Maker?
Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 7
Regencell Bioscience Holdings [RGC] is up 22.52% over the past day.
Buy
77
FARO alert for May 7
Faro Technologies [FARO] is down 0% over the past day.
Buy
53
SRPT alert for May 7
Sarepta Therapeutics [SRPT] is down 21.54% over the past day.
